Pipeline

Abon is currently seeking global partners for manufacturing and distribution for multiple proprietary technologies, as well as complex generics in the Long Acting Injectable space.

505(b)(2) Portfolio:

  •   Extended-release oral dosage form for poorly soluble amine drugs. Patent # US 9,011,912 B2
  •   Oral transmucosal dosage form offering superior patient compliance, safety and efficacy for the treatment of Hypogonadism. Patent # US 9,352,047 B2 & # US 10,821,118 B2
  •   Oral transmucosal dosage form offering superior patient compliance, safety and efficacy for Hormone Replacement Therapy (HRT). Patent # US 9,795,616 B2
  •   Long Acting Injection from Solution for psychotherapeutic drug. Patent Filed
  •   Long Acting Injection from Suspension for psychotherapeutic drug. Patent Filed
  •   Intravenous Delivery System for chemotherapy drugs. Patent Filed
  •   Improved delivery system for an inhibitor of glucosylceramide synthase to overcome metabolic variability. Patent Filed

Long-Acting Injectable Generics:

  •   Polypeptide for cancer treatment
  •   Biodegradable microsphere for a psychotherapeutic drug
  •   Biodegradable microsphere for acromegaly and certain cancers
  •   Microparticle Suspension for a psychotherapeutic drug
  • Images of Long-Acting Injectable Generics
  • © 2021 Abon Pharmaceuticals, LLC